ADVANCED MALIGNANT SOLID TUMOR
Clinical trials for ADVANCED MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug GEN1057 tested in humans – trial ends early
Disease control TerminatedThis early-stage trial tested a new antibody called GEN1057 in 23 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose. The trial was terminated early, so results are limited.
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New study explores how liver issues affect cancer drug levels
Knowledge-focused TerminatedThis study looked at how the drug tazemetostat is absorbed and processed in people with advanced cancer who also have moderate or severe liver problems. Researchers compared these participants to those with normal liver function. The goal was to understand safety and drug levels …
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Epizyme, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:35 UTC